CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma

The cylindromatosis (CYLD) gene is involved in tumor progression by acting as a negative regulator of nuclear factor-κB (NF-κB). However, the clinical significance of CYLD in patients with hepatocellular carcinoma (HCC) remains unclear. To demonstrate the clinical significance of CYLD expression, we...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: KINOSHITA, HIROKI, OKABE, HIROHISA, BEPPU, TORU, CHIKAMOTO, AKIRA, HAYASHI, HIROMITSU, IMAI, KATSUNORI, MIMA, KOSUKE, NAKAGAWA, SHIGEKI, YOKOYAMA, NAOMI, ISHIKO, TAKATOSHI, SHINRIKI, SATORU, JONO, HIROFUMI, ANDO, YUKIO, BABA, HIDEO
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2013
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915496/
https://ncbi.nlm.nih.gov/pubmed/24649166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.68
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים